AbbVie, Inc. (ABBV)
214.60
+2.30
(+1.08%)
USD |
NYSE |
May 21, 16:00
214.60
0.00 (0.00%)
After-Hours: 19:59
AbbVie Research and Development Expense (TTM) : 9.501B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.514B |
| Biogen, Inc. | 1.607B |
| Gilead Sciences, Inc. | 5.703B |
| Regeneron Pharmaceuticals, Inc. | 5.526B |
| Moderna, Inc. | 2.69B |